The role of PPARγ in advanced glycation end products-induced inflammatory response in human chondrocytes

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Ma, Chi ^a   Zhang, Ying ^a   Li, Yu Qing ^a   Chen, Cheng ^a   Cai, Wei ^a   Zeng, Yue Lin ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; INTERLEUKIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CARTILAGE CELL; CELL NUCLEUS; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; HUMAN; HUMAN CELL; INFLAMMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; WESTERN BLOTTING; AGONISTS; ARTICULAR CARTILAGE; CELL CULTURE; CHEMICALLY INDUCED; CHONDROCYTE; CYTOLOGY; DRUG EFFECTS; FEMALE; MALE; METABOLISM;

ADULT; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 13; PPAR GAMMA; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84934982473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125776     Document Type: Article

References (36)

1. Shane AA, Loeser RF. Why is osteoarthritis an age-related disease. Best Pract Res Clin Rheumatol. 2010;24:15-26. doi: 10.1016/j.berh.2009.08.006 PMID: 20129196
2. Loeser RF. Aging processes and the development of osteoarthritis. Curr Opin Rheumatol. 2013;25:108-113. doi: 10.1097/BOR.0b013e32835a9428 PMID: 23080227
3. Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med. 1998;218:23-37. PMID: 9572149
4. Schmidt AM, Yan SD, Stern DM. The dark side of glucose. Nat Med. 1995;1:1002-1004. PMID: 7489352
5. Chen YJ, Sheu ML, Tsai KS, Yang RS, Liu SH. Advanced glycation end products induce peroxisome proliferator-activated receptor gamma down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products. PLoS One. 2013;8:e66611. doi: 10.1371/journal.pone.0066611 PMID: 23776688
6. Rasheed Z, Akhtar N, Haqqi TM. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogenactivated protein kinases and nuclear factor-kappaB in human osteoarthritis chondrocytes. Rheumatology (Oxford). 2011;50:838-851. doi: 10.1093/rheumatology/keq380 PMID: 21172926
7. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147-1156. PMID: 8001151
8. Kobayashi T, Notoya K, Naito T, Unno S, Nakamura A, Martel-Pelletier J, et al. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs. Arthritis Rheum. 2005;52:479-487. PMID: 15692987
9. Lin TH, Tang CH, Wu K, Fong YC, Yang RS, Fu WM. 15-deoxy-Delta (12, 14)-prostaglandin-J2 and ciglitazone inhibit TNF-alpha-induced matrix metalloproteinase 13 production via the antagonism of NF-kappaB activation in human synovial fibroblasts. J Cell Physiol. 2011;226:3242-3250. doi: 10. 1002/jcp. 22685 PMID: 21344384
10. Yang Q, Chen C, Wu S, Zhang Y, Mao X, Wang W. Advanced glycation end products downregulates peroxisome proliferator-activated receptor gamma expression in cultured rabbit chondrocyte through MAPK pathway. Eur J Pharmacol. 2010;649:108-114. doi: 10.1016/j.ejphar.2010.09.025 PMID: 20863825
11. Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol. 2013;146:185-196. doi: 10.1016/j.clim.2012.12.011 PMID: 23360836
12. Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford). 1999;38:1275-1278. PMID: 10587559
13. Cho MC, Lee K, Paik SG, Yoon DY. Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Res. 2008;2008:679137. doi: 10.1155/2008/679137 PMID: 18566691
14. Szanto A, Nagy L. The many faces of PPARgamma: anti-inflammatory by any means. Immunobiology. 2008;213:789-803. doi: 10.1016/j.imbio.2008.07.015 PMID: 18926294
15. Nebbaki SS, El MFE, Afif H, Kapoor M, Benderdour M, Pelletier JP, et al. Expression of peroxisome proliferator-activated receptors alpha, beta, gamma, and H- and L-prostaglandin D synthase during osteoarthritis in the spontaneous hartley guinea pig and experimental dog models. J Rheumatol. 2013;40:877-890. doi: 10.3899/jrheum.120738 PMID: 23547214
16. Vasheghani F, Monemdjou R, Fahmi H, Zhang Y, Perez G, Blati M, et al. Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype. Am J Pathol. 2013;182:1099-1106. doi: 10.1016/j.ajpath.2012.12.012 PMID: 23375622
17. Boileau C, Martel-Pelletier J, Fahmi H, Mineau F, Boily M, Pelletier JP. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways. Arthritis Rheum. 2007;56:2288-2298. PMID: 17599749
18. Monemdjou R, Vasheghani F, Fahmi H, Perez G, Blati M, Taniguchi N, et al. Association of cartilagespecific deletion of peroxisome proliferator-activated receptor gamma with abnormal endochondral ossification and impaired cartilage growth and development in a murine model. Arthritis Rheum. 2012;64:1551-1561. doi: 10.1002/art.33490 PMID: 22131019
19. Ji JD, Cheon H, Jun. JB, Choi SJ, Kim YR, Lee YH, et al. Effects of peroxisome proliferator-activated receptorgamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes. J Autoimmun. 2001;17:215-221. PMID: 11712859
20. Ishibashi Y, Matsui T, Ohta K, Tanoue R, Takeuchi M, Asanuma K, et al. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation. Microvasc Res. 2013;85:54-58. doi: 10.1016/j.mvr. 2012.10.007 PMID: 23108227
21. Li F, Cai Z, Chen F, Shi X, Zhang Q, Chen S, et al. Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products. Basic Res Cardiol. 2012;107:306. doi: 10.1007/s00395-012-0306-0 PMID: 23070070
22. Puddu A, Sanguineti R, Durante A, Viviani GL. Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. Regul Pept. 2012;177:79-84. doi: 10.1016/j.regpep. 2012.05.089 PMID: 22587907
23. Yuan X, Liu N. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells. J Genet Genomics. 2011;38:193-200. doi: 10.1016/j.jgg.2011.04.001 PMID: 21621740
24. Zhang Y, Luo Z, Ma L, Xu Q, Yang Q, Si L. Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int J Mol Med. 2010;25:729-734. PMID: 20372816
25. Liang C, Ren Y, Tan H, He Z, Jiang Q, Wu J, et al. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br J Pharmacol. 2009;158:1865-1873. doi: 10.1111/j.1476-5381.2009.00450.x PMID: 19917066
26. Yamagishi S, Nakamura K, Matsui T. Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease. Pharmacol Res. 2009;60:174-178. doi: 10.1016/j.phrs.2009.01.006 PMID: 19646657
27. Lin J, Tang Y, Kang Q, Feng Y, Chen A. Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARgamma activity and attenuating oxidative stress. Br J Pharmacol. 2012;166:2212-2227. doi: 10.1111/j.1476-5381.2012. 01910.x PMID: 22352842
28. Jiang LY, Tang SS, Wang XY, Liu LP, Long Y, Hu M, et al. PPARgamma agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. CNS Neurosci Ther. 2012;18:659-666. doi: 10.1111/j.1755-5949.2012.00341.x PMID: 22620268
29. Cortizo AM, Lettieri MG, Barrio DA, Mercer N, Etcheverry SB, McCarthy AD. Advanced glycation endproducts (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol Cell Biochem. 2003;250:1-10. PMID: 12962137
30. Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, Munch G. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem. 2003;87:44-55. PMID: 12969251
31. Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ, et al. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum. 2005;52:2376-2385. PMID: 16052547
32. Rasheed Z, Anbazhagan AN, Akhtar N, Ramamurthy S, Voss FR, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther. 2009;11:R71. doi: 10.1186/ar2700 PMID: 19445683
33. Nah SS, Choi IY, Lee CK, Oh JS, Kim YG, Moon HB, et al. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford). 2008;47:425-431. doi: 10.1093/rheumatology/kem376 PMID: 18285354
34. Nah SS, Choi IY, Yoo B, Kim YG, Moon HB, Lee CK. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes. FEBS Lett. 2007;581:1928-1932. PMID: 17434489
35. Mahali SK, Manna SK. Beta-D-glucoside protects against advanced glycation end products (AGEs) - mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding. Biochem Pharmacol. 2012;84:1681-1690. doi: 10.1016/j.bcp. 2012.09.033 PMID: 23058985
36. Burgermeister E, Chuderland D, Hanoch T, Meyer M, Liscovitch M, Seger R. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol. 2007;27:803-817. PMID: 17101779